B-type natriuretic peptide for prevention of contrast-induced nephropathy in patients with heart failure undergoing primary percutaneous coronary intervention.

@article{Zhang2010BtypeNP,
  title={B-type natriuretic peptide for prevention of contrast-induced nephropathy in patients with heart failure undergoing primary percutaneous coronary intervention.},
  author={Jing Zhang and Xianghua Fu and Xinwei Jia and Xinna Fan and Xinshun Gu and Shiqiang Li and Weili Wu and Weize Fan and Jianling Su and Guozhen Hao and Yunfa Jiang and Liyao. Xue},
  journal={Acta radiologica},
  year={2010},
  volume={51 6},
  pages={
          641-8
        }
}
BACKGROUND Contrast-induced nephropathy (CIN) is one of the leading causes of hospital-acquired renal failure and increase in the mortality and length of hospital stay after percutaneous coronary intervention (PCI). PURPOSE To evaluate the protective effect of B-type natriuretic peptide (BNP) on CIN in patients with heart failure undergoing PCI. MATERIAL AND METHODS In the prospective, placebo-controlled, randomized trial, 149 consecutive acute myocardial infarction (AMI) patients with… CONTINUE READING
BETA
2
Twitter Mentions

Similar Papers

Citations

Publications citing this paper.
SHOWING 1-10 OF 15 CITATIONS

Brain natriuretic peptide for prevention of contrast-inducednephropathy: a meta-analysis of randomized controlled trials

  • European Journal of Clinical Pharmacology
  • 2016
VIEW 15 EXCERPTS
CITES BACKGROUND & RESULTS
HIGHLY INFLUENCED